Dr. Nola Hylton’s path to becoming one of the pre-eminent scientists in the field of biomedical imaging stretches back to childhood when she carried a deep curiosity about the world and “why things are as they are.” In this Q&A, Dr. Hylton talks about choosing a career that would have an impact on others, her enduring excitement for her work, and mentoring women of color in science. [read more]

Faranak Fattahi, PhD - Associate Member, Pediatric Malignancies

Christine Higham, MD - Member, Pediatric Malignancies

Jonathan Ostrem, MD, PhD - Associate Member, Molecular Oncology

Alyssa Reddy, MD - Member, Pediatric Malignancies

Matthew Spitzer, PhD was awarded an NIH R01 grant to study immune response to OED and OSCC.

George F. Sawaya, MD and co-PI Michael J Silverberg, PhD (Kaiser) received a 5-year NCI grant for a study, "Comparative Effectiveness Research to Validate and Improve Cervical Cancer Screening (CERVICCS 2)."

Peggy Reynolds, PhD, MPH and co-PI Susan Neuhausen, PhD (City of Hope) received a NIEHS R01 grant for a study, "Environmental Chemical Body Burden and Prospective Breast Cancer Risk in the Cancer Prevention Study-3 Cohort."

Iona Cheng, PhD, MPH and co-PI Lani Park, PhD (University of Hawaii) received a NCI R01 grant for their study, "Understanding the role of structural racism on racial/ethnic inequities in lung cancer risk."

Erin Van Blarigan, ScD -- along with co-investigators June Chan, ScD, Stacey Kenfield, ScD, Sorbarikor Piawah, MD, and Adrian Aguilera, PhD -- received a R21 grant for a study, "Engaging diverse colorectal cancer survivors in the design of an adaptive text message-based intervention to improve diet quality."

Amar Nijagal, MD received a UC Cancer Research Coordinating Committee (CRCC) Faculty Seed Grant for a project, "Dysregulated immune signals in the developing liver promote pediatric hepatoblastoma."

Tadashi Manabe, MD, PhD and Erron Titus, MD, PhD were named Spring 2022 Damon Runyon Fellows by the Damon Runyon Cancer Research Foundation.

Julie Ann Sosa, MD, MA, FACS received the Distinguished Service Award from the American Thyroid Association.

Kenneth Hu, PhD was named a 2022 Parker Bridge Fellow by the Parker Institute for Cancer Immunotherapy in partnership with the V Foundation for Cancer Research.

Lichter KE, Anderson J, Sim AJ, Baniel CC, Thiel CL, Chuter R, Collins A, Carollo E, Berg CD, Coleman CN, Abdel-Wahab M, Grover S, Singer L, Mohamad O. Transitioning to Environmentally Sustainable, Climate-Smart Radiation Oncology Care. Int J Radiat Oncol Biol Phys. 2022 Aug 1;113(5):915-924.

Tolani B, Celli A, Yao Y, Tan YZ, Fetter R, Liem CR, de Smith AJ, Vasanthakumar T, Bisignano P, Cotton AD, Seiple IB, Rubinstein JL, Jost M, Weissman JS. Ras-mutant cancers are sensitive to small molecule inhibition of V-type ATPases in mice. Nat Biotechnol. 2022 Jul 25. doi: 10.1038/s41587-022-01386-z. Epub ahead of print. PMID: 35879364.

Kumar A, Mohamed E, Tong S, Chen K, Mukherjee J, Lim Y, Wong CM, Boosalis Z, Shai A, Pieper RO, Gupta N, Perry A, Bollen AW, Molinaro AM, Solomon DA, Shieh JTC, Phillips JJ. CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in Glioma. Clin Cancer Res. 2022 Jul 1;28(13):2898-2910.

Zablotska LB, Lane RSD, Randhawa K. Association between exposures to radon and γ-ray radiation and histologic type of lung cancer in Eldorado uranium mining and milling workers from Canada. Cancer. 2022 Jun 29.

Harrison, J., Palmer, N., Cabrera, A., Fleisher, P., Wong, E., LeSarre, M., . . . Nguyen, T. (2022). Addressing the challenges of conducting community-engaged research during COVID-19: Rapid development and evaluation of a COVID-19 Research Patient and Community Advisory Board (PCAB). Journal of Clinical and Translational Science, 6(1), E88. doi:10.1017/cts.2022.413

PSPCO aims to foster the development of the next generation of clinical scientists to be effective partners with discovery scientists and conduct high impact and innovative patient-centered cancer research. Apply for our 2023 cohort of scholars by Dec 1, 2022. Individuals from View training plan, eligibility, and application requirements.

Aug 18: Office Hours with the CTSI Participant Recruitment Program

Stuck in a recruitment rut? Drop by to ask questions and access free resources designed to help you reach recruitment goals.

Aug 25: Protocol Structure and Review

Open to senior fellows, residents, and faculty, this seminar is part of the HDFCCC K12 Physician Scientist Program in Clinical Oncology.

Sept 12: Computational Cancer Community (C3) Meeting

Featuring Katherine Pollard, PhD, Professor of Epidemiology and Biostatistics, UCSF.

Sept 21: UCSF Faculty Development Day

A one-day event that offers workshops for professional development and resources to enhance faculty life at UCSF. Topics will be relevant to faculty in all schools and at all career stages.

Sept 26-27: 2022 QBI Chemical Biology Symposium

Focusing on the latest cutting edge chemical biology research to address unmet biological problems with new technologies and targets from top scientists in the Bay Area.